PHAGERUS Trademark

Trademark Overview

On Monday, September 12, 2022, a trademark application was filed for PHAGERUS with the United States Patent and Trademark Office. The USPTO has given the PHAGERUS trademark a serial number of 97586869. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by iNtRON Biotechnology, Inc.. The PHAGERUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
phagerus

General Information

Serial Number97586869
Word MarkPHAGERUS
Filing DateMonday, September 12, 2022
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7417182
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesResearch and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 27, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameiNtRON Biotechnology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSungnam-si,Kyeonggi-do 462-120
KR
Party NameiNtRON Biotechnology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSungnam-si,Kyeonggi-do 462-120
KR
Party NameiNtRON Biotechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSungnam-si,Kyeonggi-do 462-120
KR

Trademark Events

Event DateEvent Description
Thursday, January 5, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 15, 2022NEW APPLICATION ENTERED
Tuesday, September 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 30, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023SUSPENSION LETTER WRITTEN
Thursday, January 5, 2023LETTER OF SUSPENSION E-MAILED
Thursday, July 6, 2023SUSPENSION INQUIRY WRITTEN
Thursday, July 6, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, July 6, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 13, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 22, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 2, 2024ASSIGNED TO LIE
Friday, February 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 2, 2024SUSPENSION LETTER WRITTEN
Friday, February 2, 2024LETTER OF SUSPENSION E-MAILED
Friday, February 2, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 5, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 8, 2024NON-FINAL ACTION WRITTEN
Thursday, February 8, 2024NON-FINAL ACTION E-MAILED
Thursday, February 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

phagerus drug pharmaceutical vaccine biotech products relating sectors substance development research